KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$2.49
+2.89%
Mkt Cap $65.65M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$17.00
Range $17.00 – $17.00
Implied Upside
+582.7%
Consensus $17.00 vs current $2.49
NASDAQ·Healthcare·Biotechnology
$2.49
+2.89%
Mkt Cap $65.65M
No recent rating data.
Price Target (5 analysts)
$17.00
Range $17.00 – $17.00
+582.7%
Consensus $17.00 vs current $2.49